Abich Financial Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Abich Financial Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$176K	Buy	+275	New	+$167K	0.06%	139

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Abich Financial Wealth Management's IDXX Position: Q3 2025 in Review

Abich Financial Wealth Management opened a new position in Idexx Laboratories (IDXX) in Q3 2025: 275 shares worth $176K. The stake represents 0.06% of the portfolio and ranks #139 among its holdings.

1,303 funds tracked by Wall St. Rank hold IDXX as of Q3 2025.

Abich Financial Wealth Management held 275 shares of Idexx Laboratories worth $176K as of Q3 2025.
Idexx Laboratories was a new Abich Financial Wealth Management position in Q3 2025.
Idexx Laboratories made up 0.06% of Abich Financial Wealth Management's portfolio in Q3 2025, its #139 holding.
1,303 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2025.

Based on Abich Financial Wealth Management's 13F filing for Q3 2025, filed 6 Nov 2025.